Zdrowie i gospodarka · 08/09/1999

FDA Releases Draft Guidance on Bioequivalence Studies

The Food and Drug Administration (FDA) has made available a draft guidance document outlining recommendations for industry sponsors on establishing bioequivalence, a crucial step in the development of new drugs, and is expected to replace two previous guidances once finalized.